A Synthetic Receptor Enables Breakthrough Scale Manufacturing of iPSC-Derived CD19-CAR Cell Therapies for Hematologic and Autoimmune DiseasesDillon K. Jarrell, Samantha Ohara, Cassidy Arnold et al.|Blood|2024Cited by 0